INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "THERAPY FOR NEUROFIBROMATOSIS TYPE 1"

GENEVA, March 31 -- THE JOHNS HOPKINS UNIVERSITY (3400 North Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/US2025/046972) for "THERAPY FOR NEUROFIBROMATOSIS TYPE 1" on Sep 18, 2025. With publication no. WO/2026/064511, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAI, Renyuan (c/o The Johns Hopkins University3400 North Charles StreetBaltimore, Maryland 21218)

Abstract: This application describes a technology relating to treating neurofibromatosis type 1 and particularly, but not exclusively,...